Home>>Vitamin e reduces superficial bladder cancer recurrence: a randomized controlled trial.

Search

About

Authors:
Address: Department of Urology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Journal:


Publication:
Free Text: Vitamin e reduces superficial bladder cancer recurrence: a randomized controlled trial.


abstract

BACKGROUND:

Most patients with superficial bladder cancer who undergo transurethral resection of bladder tumor show recurrence of the disease. So far, there have been numerous studies on ways to decrease bladder cancer recurrence, including the intake of Vitamins and antioxidants. The goal of this study was to investigate the effect of vitamin E on the recurrence of non-invasive bladder cancer.

METHODS:

In this randomized controlled trial, 46 patients with a single, low-grade, superficial bladder cancer, less than 3 cm in diameter, were randomly divided into two groups of vitamin E intake (400 IU daily) and no intake of vitamin E. Ultrasound and urinalysis were performed every three months to detect bladder cancer recurrence.

RESULTS:

There was no significant difference between the groups in age, tumor size, mean time to recurrence, and follow-up time. There recurrence rate was 28.3% throughout the follow-up period (19% in the study group and 36% in the controls) (CI=0.19 - 0.92, RR=0.53, CI=0.11 - 0.94, OR=0.42, P=0.04). In both groups, most (69.2%) of the recurrences occurred during the first year.The rate of recurrence decreased in smokers from 50% in the study group to 25% in the control group (P=0.06) and from 26.7% to 15.4% in the non-smokers in the control and study groups, respectively (P=0.15).

CONCLUSION:

Intake of vitamin E significantly decreased bladder cancer recurrence, especially among smokers, possibly due to higher levels of oxidants, which vitamin E may target in smokers.The trial registry code: IRCT201105235527N2.



Related Articles
Final Report on Carcinogens Background Document for Formaldehyde.
Rep Carcinog Backgr Doc. 2010
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program. Rep Carcinog Backgr Doc. 2010 Jan; (10-5981):i-512.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program. Rep Carcinog Backgr Doc. 2008 Sep; (8-5978):i-398.
Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up.
J Egypt Natl Canc Inst. 2007
Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up.
El-Ghobashy S, El-Leithy TR, Roshdy MM, El-Ganzoury HM. J Egypt Natl Canc Inst. 2007 Jun; 19(2):121-6.
Review Chemoprevention of bladder cancer.
Urol Clin North Am. 2002
Review Chemoprevention of bladder cancer.
Kamat AM, Lamm DL. Urol Clin North Am. 2002 Feb; 29(1):157-68.
Review Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Health Technol Assess. 2010
Review Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P. Health Technol Assess. 2010 Jun; 14(32):1-206.